Jilin Aodong Pharmaceutical Group Co Ltd Capital Reinvestment Ratio
Jilin Aodong Pharmaceutical Group Co Ltd capital reinvestment ratio. Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥112.12 Million) in capital expenditures (CN¥25.80 Million). See how much free cash does Jilin Aodong Pharmaceutical Group Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Capital reinvestment ratio of Jilin Aodong Pharmaceutical Group Co Ltd from 1999 to 2025. This chart tracks Jilin Aodong Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 26 annual periods. See how financially flexible is Jilin Aodong Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
Jilin Aodong Pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (1999–2025)
Jilin Aodong Pharmaceutical Group Co Ltd capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see 000623 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | CN¥272.26 Million | CN¥128.45 Million | ▼ -89.8% |
| 2024 | 4.61x | CN¥59.48 Million | CN¥273.98 Million | ▼ -25.3% |
| 2023 | 6.16x | CN¥68.06 Million | CN¥419.52 Million | ▲ +864.2% |
| 2022 | 0.64x | CN¥423.86 Million | CN¥270.97 Million | ▼ -33.7% |
| 2021 | 0.96x | CN¥324.85 Million | CN¥313.30 Million | ▲ +65.6% |
| 2020 | 0.58x | CN¥390.41 Million | CN¥227.38 Million | ▼ -0.6% |
| 2019 | 0.59x | CN¥379.46 Million | CN¥222.40 Million | ▼ -16.9% |
| 2018 | 0.71x | CN¥347.64 Million | CN¥245.30 Million | ▲ +115.6% |
| 2017 | 0.33x | CN¥256.49 Million | CN¥83.93 Million | ▼ -30.9% |
| 2016 | 0.47x | CN¥333.81 Million | CN¥158.03 Million | ▼ -45.0% |
| 2015 | 0.86x | CN¥388.03 Million | CN¥334.11 Million | ▼ -38.1% |
| 2014 | 1.39x | CN¥288.83 Million | CN¥402.01 Million | ▼ -9.4% |
| 2013 | 1.54x | CN¥201.22 Million | CN¥309.01 Million | ▲ +28.0% |
| 2012 | 1.20x | CN¥272.40 Million | CN¥326.80 Million | ▼ -71.6% |
| 2011 | 4.23x | CN¥108.30 Million | CN¥457.72 Million | ▲ +384.4% |
| 2010 | 0.87x | CN¥174.22 Million | CN¥152.00 Million | ▲ +409.0% |
| 2009 | 0.17x | CN¥213.03 Million | CN¥36.51 Million | ▲ +27.8% |
| 2008 | 0.13x | CN¥235.03 Million | CN¥31.52 Million | ▲ +31.5% |
| 2007 | 0.10x | CN¥384.69 Million | CN¥39.24 Million | ▼ -66.3% |
| 2006 | 0.30x | CN¥187.99 Million | CN¥56.87 Million | ▼ -26.0% |
| 2005 | 0.41x | CN¥136.26 Million | CN¥55.68 Million | ▲ +93.4% |
| 2004 | 0.21x | CN¥218.53 Million | CN¥46.19 Million | ▼ -66.0% |
| 2003 | 0.62x | CN¥147.65 Million | CN¥91.89 Million | ▼ -58.4% |
| 2001 | 1.49x | CN¥138.76 Million | CN¥207.37 Million | ▼ -29.8% |
| 2000 | 2.13x | CN¥77.04 Million | CN¥163.90 Million | ▲ +232.4% |
| 1999 | 0.64x | CN¥110.18 Million | CN¥70.52 Million | — |